In May 2024, cancer specialists from around the world came together to attend the virtual 2nd China-Europe Anti-Cancer Summit, co-organised by the China Anti-Cancer Association (CACA) and the Latin-American & Caribbean Society of Medical Oncology (SLACOM).

 

Anti-cancer leaders from China and Europe took part in presentations and a panel discussion and exchanged ideas and perspectives on the following:

  • Development of holistic integrative management of cancer in China
  • Status and challenges of cancer prevention and control in Europe
  • A new anti-cancer paradigm by activation of thermogenic adipose tissue

 

 

Organised by CACA and SLACOM


 

Co-organised by eChinaHealth and COR2ED


China-Europe Anti-Cancer Summit 2024: Educational objectives

 

  • Share insights and perspectives on the management and treatment of cancer patients in China and Europe
  • Generate awareness of the latest innovations and progress in cancer research in China and Europe

Programme summary
  • clock Duration 101 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from BeiGene.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from BeiGene.
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

blueprint BluePrintInfographic / Flashcard
Oncology 
Biomarker testing in non-small cell lung cancer (NSCLC)

Insights from patients and caregivers

Experts
Prof. Christian Rolfo, Prof. Fernando López-Ríos, Dr Rodrigo Paredes de la Fuente, Anne-Marie Baird, Amy C. Moore, Shani Shilo
Endorsed by
LUNGevity The Israeli Lung Cancer Foundation
Biomarker Collaborative NTRKers
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jul 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Bayer.
micro-learning Micro learning - Video, slides and more
Oncology 
The evolving treatment landscape in HER2-mutant NSCLC

Expert insights on how the latest evidence is shaping clinical practice

Experts
Dr Devika Das, Dr Tom Newsom-Davis
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jul 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Bayer
animated-video Animated Video
Oncology 
The critical role of testing and management in NTRK-positive non-small cell lung cancer (NSCLC)

Using molecular testing to enable personalised care

Experts
Dr Herbert Loong
Endorsed by
ICAN international cancer advocacy network ISLB NTRKers
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jun 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Bayer.
symposium Masterclass / Symposium
Oncology 
ER+/HER2- metastatic breast cancer: ESMO Breast Cancer 2026 Satellite Symposium highlights

Experts discuss 2nd line+ treatment strategies in endocrine therapy-eligible patients

Experts
Prof. Nadia Harbeck, Dr Tiffany Traina, Prof. Frederik Marmé
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Jun 2026

This programme has been sponsored by Menarini Stemline and is intended for HCPs only.
conference-update Conference update
Oncology 
Highlights from ASCO 2026

Expert insights on the latest data

Experts
Dr Herbert Loong, Dr Isabel Preeshagul, Prof. Mark Socinski, Prof. Evan Yu, Prof. Hans Prenen, Dr Paolo Tarantino
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Jun 2026
  • Non-accredited Independent Medical Education

Infographic / Flashcard
Oncology Rare diseases 
EP-NEC at a glance

Understanding EP-NEC, emerging treatments, and patient care strategies

Experts
Meredith Cummins
  • download Downloadable
    Resources
  • clock 1 MIN
  • calendar May 2026

This programme has been sponsored by Boehringer Ingelheim